Klas Therapeutics

Description: Klas Therapeutics develops peptide-photosensitiser conjugates activated by photodynamic therapy to treat melanoma, showing 99% tumor death in preclinical studies.

Country: UK

Based in: Belfast

Founded: 2021

Funding Stage: Pre-Seed

Tags: ['Health', 'Human Services', 'Therapy']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.